Cargando…
Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis
Immunotherapy is the newest approach to combat cancer. It can be achieved using several strategies, among which is the dendritic cell (DC) vaccine therapy. Several clinical trials are ongoing using DC vaccine therapy either as a sole agent or in combination with other interventions to tackle differe...
Autores principales: | Saadeldin, Mona Kamal, Abdel-Aziz, Amal Kamal, Abdellatif, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836805/ https://www.ncbi.nlm.nih.gov/pubmed/33221134 http://dx.doi.org/10.1016/j.mehy.2020.110365 |
Ejemplares similares
-
Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review)
por: Fathallah, Sara, et al.
Publicado: (2023) -
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2022) -
Cancer immunotherapy: the beginning of the end of cancer?
por: Farkona, Sofia, et al.
Publicado: (2016) -
Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study
por: Saadeldin, Mona Kamal, et al.
Publicado: (2018) -
The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?
por: Jhaveri, Ravi
Publicado: (2021)